360 related articles for article (PubMed ID: 20537987)
1. Characterization of [(3)H]CHIBA-1001 binding to alpha7 nicotinic acetylcholine receptors in the brain from rat, monkey, and human.
Tanibuchi Y; Wu J; Toyohara J; Fujita Y; Iyo M; Hashimoto K
Brain Res; 2010 Aug; 1348():200-8. PubMed ID: 20537987
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterization of [(125)I]CHIBA-1006 binding, a new radioligand for α7 nicotinic acetylcholine receptors, to rat brain membranes.
Wu J; Toyohara J; Tanibuchi Y; Fujita Y; Zhang J; Chen H; Matsuo M; Wang RF; Hashimoto K
Brain Res; 2010 Nov; 1360():130-7. PubMed ID: 20816767
[TBL] [Abstract][Full Text] [Related]
3. [11C]CHIBA-1001 as a novel PET ligand for alpha7 nicotinic receptors in the brain: a PET study in conscious monkeys.
Hashimoto K; Nishiyama S; Ohba H; Matsuo M; Kobashi T; Takahagi M; Iyo M; Kitashoji T; Tsukada H
PLoS One; 2008 Sep; 3(9):e3231. PubMed ID: 18800169
[TBL] [Abstract][Full Text] [Related]
4. [3H]A-585539 [(1S,4S)-2,2-dimethyl-5-(6-phenylpyridazin-3-yl)-5-aza-2-azoniabicyclo[2.2.1]heptane], a novel high-affinity alpha7 neuronal nicotinic receptor agonist: radioligand binding characterization to rat and human brain.
Anderson DJ; Bunnelle W; Surber B; Du J; Surowy C; Tribollet E; Marguerat A; Bertrand D; Gopalakrishnan M
J Pharmacol Exp Ther; 2008 Jan; 324(1):179-87. PubMed ID: 17959745
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and the first clinical studies on [11C]CHIBA-1001 for mapping alpha7 nicotinic receptors by positron emission tomography.
Toyohara J; Sakata M; Wu J; Ishikawa M; Oda K; Ishii K; Iyo M; Hashimoto K; Ishiwata K
Ann Nucl Med; 2009 May; 23(3):301-9. PubMed ID: 19337782
[TBL] [Abstract][Full Text] [Related]
6. An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.
Yin L; Zhao Q; Li L; Zhang SL; Chen XQ; Ma C; Kang L; Liu M; Zhang CL; Yan P; Wang RF
PLoS One; 2013; 8(7):e70188. PubMed ID: 23936161
[TBL] [Abstract][Full Text] [Related]
7. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain.
Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A
Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933
[TBL] [Abstract][Full Text] [Related]
8. High-affinity epibatidine binding of functional, human alpha7-nicotinic acetylcholine receptors stably and heterologously expressed de novo in human SH-EP1 cells.
Peng JH; Fryer JD; Hurst RS; Schroeder KM; George AA; Morrissy S; Groppi VE; Leonard SS; Lukas RJ
J Pharmacol Exp Ther; 2005 Apr; 313(1):24-35. PubMed ID: 15590768
[TBL] [Abstract][Full Text] [Related]
9. An autoradiographic study of the distribution of binding sites for the novel alpha7-selective nicotinic radioligand [3H]-methyllycaconitine in the mouse brain.
Whiteaker P; Davies AR; Marks MJ; Blagbrough IS; Potter BV; Wolstenholme AJ; Collins AC; Wonnacott S
Eur J Neurosci; 1999 Aug; 11(8):2689-96. PubMed ID: 10457165
[TBL] [Abstract][Full Text] [Related]
10. [³H]Chiba-1001(methyl-SSR180711) has low in vitro binding affinity and poor in vivo selectivity to nicotinic alpha-7 receptor in rodent brain.
Ding M; Ghanekar S; Elmore CS; Zysk JR; Werkheiser JL; Lee CM; Liu J; Chhajlani V; Maier DL
Synapse; 2012 Apr; 66(4):315-22. PubMed ID: 22108786
[TBL] [Abstract][Full Text] [Related]
11. Gene targeting demonstrates that alpha4 nicotinic acetylcholine receptor subunits contribute to expression of diverse [3H]epibatidine binding sites and components of biphasic 86Rb+ efflux with high and low sensitivity to stimulation by acetylcholine.
Marks MJ; Meinerz NM; Drago J; Collins AC
Neuropharmacology; 2007 Sep; 53(3):390-405. PubMed ID: 17631923
[TBL] [Abstract][Full Text] [Related]
12. Presynaptic alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate [3H]d-aspartate release from rat frontal cortex in vitro.
Rousseau SJ; Jones IW; Pullar IA; Wonnacott S
Neuropharmacology; 2005 Jul; 49(1):59-72. PubMed ID: 15992581
[TBL] [Abstract][Full Text] [Related]
13. In vitro binding characteristics of [3H]AZ11637326, a novel alpha7-selective neuronal nicotinic receptor agonist radioligand.
Gordon JC; Phillips E; Gurley DA; Heys JR; Lazor LA; Barthlow HG; Mallamaci MA; Keith RA
Eur J Pharmacol; 2010 Oct; 645(1-3):63-9. PubMed ID: 20674564
[TBL] [Abstract][Full Text] [Related]
14. [125I]Iodomethyllycaconitine binds to alpha7 nicotinic acetylcholine receptors in monkey brain.
Kulak JM; Carroll FI; Schneider JS
Eur J Neurosci; 2006 May; 23(10):2604-10. PubMed ID: 16817863
[TBL] [Abstract][Full Text] [Related]
15. Localization of [3H]nicotine, [3H]cytisine, [3H]epibatidine, and [125I]alpha-bungarotoxin binding sites in the brain of Macaca mulatta.
Han ZY; Zoli M; Cardona A; Bourgeois JP; Changeux JP; Le Novère N
J Comp Neurol; 2003 Jun; 461(1):49-60. PubMed ID: 12722104
[TBL] [Abstract][Full Text] [Related]
16. Combined α7 nicotinic acetylcholine receptor agonism and partial serotonin transporter inhibition produce antidepressant-like effects in the mouse forced swim and tail suspension tests: a comparison of SSR180711 and PNU-282987.
Andreasen JT; Redrobe JP; Nielsen EØ
Pharmacol Biochem Behav; 2012 Jan; 100(3):624-9. PubMed ID: 22108649
[TBL] [Abstract][Full Text] [Related]
17. SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.
Biton B; Bergis OE; Galli F; Nedelec A; Lochead AW; Jegham S; Godet D; Lanneau C; Santamaria R; Chesney F; Léonardon J; Granger P; Debono MW; Bohme GA; Sgard F; Besnard F; Graham D; Coste A; Oblin A; Curet O; Vigé X; Voltz C; Rouquier L; Souilhac J; Santucci V; Gueudet C; Françon D; Steinberg R; Griebel G; Oury-Donat F; George P; Avenet P; Scatton B
Neuropsychopharmacology; 2007 Jan; 32(1):1-16. PubMed ID: 17019409
[TBL] [Abstract][Full Text] [Related]
18. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
[TBL] [Abstract][Full Text] [Related]
19. Type I and II positive allosteric modulators differentially modulate agonist-induced up-regulation of α7 nicotinic acetylcholine receptors.
Thomsen MS; Mikkelsen JD
J Neurochem; 2012 Oct; 123(1):73-83. PubMed ID: 22804734
[TBL] [Abstract][Full Text] [Related]
20. Modulation of α7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer's disease brain.
Ni R; Marutle A; Nordberg A
J Alzheimers Dis; 2013; 33(3):841-51. PubMed ID: 23042213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
